Castillo could have one of the highest grade copper deposits in Australia

|

Published 11-DEC-2018 12:23 P.M.

|

2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

Castillo Copper (ASX:CCZ) has today reported highly promising diamond drill core assay results for drill-hole CC0036D, which validate the high-grade nature of the underlying ore body at the ASX small cap’s Cangai Copper Mine.

The best intersection, from 9.6m of highly mineralised core extracted, was 4.37m at 5.06% copper, 2.56% zinc and 22.7 g/t silver from 49.9m.

Notably, within this section, the best readings were up to 14.45% copper, 5.93% zinc & 40.1g/t silver (results are still pending for gold).

Diamond drill core samples 1 & 2.

Castillo chairman, Peter Meagher, said: “The assay results from the diamond drill core significantly exceeded the board’s expectations, especially the 14.45% copper reading.

“Clearly, in the board’s view, Cangai Copper Mine is one of the highest grading copper deposits across Australia.

“The board’s strategic intent has broadened to encompass, firstly, determining the scalability of the high-grade ore body at Cangai Copper Mine through more DHEM survey work and RC-drilling; and, secondly, capitalise on incremental exploration upside through flying aero-magnetic surveys over pre-selective parts of the Cangai South tenure to identify new high-grade targets.”

Encouragingly, these diamond core results build on the RC drilling assays from drill-hole CC0023R, which delivered 11m at 5.94% copper, 2.45% zinc & 19.1 g/t silver from 40m including 1m at 10.25% copper, 1.68% zinc & 32.5 g/t silver from 48m.

From the board’s perspective, a look at these results combined indicates that the Cangai Copper Mine could have one of the highest grading copper deposits in Australia.

CCZ advises on immediate priorities post-results

In light of the results, CCZ’s board has now mapped out its near-term exploration plans.

The immediate priority for the small cap now will be to complete the phase II campaign testing DHEM conductors identified under the Mark’s, Greenberg’s and Volkhardts lodes to determine any potential extensions to known massive sulphide mineralisation.

CCZ’s massive sulphide DHEM conductors at Cangai copper mine.

Furthermore, the company will conduct additional DHEM surveys to identify new targets that expand the known orebody to demonstrate scalability at Cangai Copper Mine.

Compared with other regions, minimal exploration, especially utilising advanced technology, has been undertaken across CCZ’s ground since the early 1990s. Previous desktop work by the geology team confirms the region is largely under-explored but is highly prospective for copper-zinc-cobalt mineralisation.

Stockpile offtake deal

Last month, CCZ updated the market on its arrangements with Noble Group (SGX:CGP) to progress metallurgical test-work on all legacy stockpiles at Cangai.

As part of its agreement with Noble, CCZ’s geology team has collected samples from the stockpiles around the Cangai Copper Mine and the old smelter. The samples have been sent to a specialist metallurgical group offshore for third party verification and optimisation. Metallurgical test-work done on samples from McDonoughs’ stockpile demonstrated copper concentrate recoveries of >80%, with grades up to 22%.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X